beta-apo-10'-carotenal: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
10'-apo-beta-carotenal : An apo carotenoid compound arising from oxidative degradation of the beta,beta-carotene skeleton at the 10'-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 6450190 |
CHEBI ID | 53153 |
SCHEMBL ID | 2831303 |
MeSH ID | M0389781 |
Synonym |
---|
beta-apo-10'-carotenal |
10'-apo-beta-carotenal, all-trans- |
640-49-3 |
10'-apo-beta-caroten-10'-al |
10'-apo-beta,psi-carotenal |
10'-apo-beta-carotenal |
all-trans-10'-apo-beta-carotenal |
CHEBI:53153 |
(2e,4e,6e,8e,10e,12e,14e)-4,9,13-trimethyl-15-(2,6,6-trimethylcyclohexen-1-yl)pentadeca-2,4,6,8,10,12,14-heptaenal |
C20695 |
SCHEMBL2831303 |
Q27123983 |
DTXSID701315499 |
apo-beta,psi-carotenal, 10'- |
2,4,6,8,10,12,14-pentadecaheptaenal, 4,9,13-trimethyl- |
(2e,4e,6e,8e,10e,12e,14e)-4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8,10,12,14-pentadecaheptaenal |
2,4,6,8,10,12,14-pentadecaheptaenal, 4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-e)- |
2,4,6,8,10,12,14-pentadecaheptaenal, 4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2e,4e,6e,8e,10e,12e,14e)- |
D8AT287SHE |
Class | Description |
---|---|
enal | An alpha,beta-unsaturated aldehyde of general formula R(1)R(2)C=CR(3)-CH=O in which the aldehydic C=O function is conjugated to a C=C double bond at the alpha,beta position. |
apo carotenoid | A compound arising from loss of part of the carotene skeleton (excluding retinoids) |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathway | Proteins | Compounds |
---|---|---|
Metabolism | 1496 | 1108 |
Metabolism of vitamins and cofactors | 146 | 155 |
Metabolism of fat-soluble vitamins | 26 | 23 |
Retinoid metabolism and transport | 22 | 17 |
Visual phototransduction | 62 | 41 |
carotenoid cleavage | 6 | 20 |
Sensory Perception | 215 | 68 |
carotenoid cleavage | 4 | 22 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 9 (75.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.60) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |